Liberty Wealth Management LLC Next Cure, Inc. Transaction History

Liberty Wealth Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$5.7 - $9.1 $1,140 - $1,820	-200 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$7.6 - $10.28 $10,685 - $14,453	-1,406 Reduced 87.55%	200 $2,000
Q2 2021 Aug 13, 2021	BUY	$7.6 - $10.28 $10,685 - $14,453	1,406 Added 703.0%	1,606 $200,000
Q2 2020 Aug 04, 2020	BUY	$21.19 - $40.2 $4,238 - $8,040	200 New	200 $4,000

14.6M

Ticker NXTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,748,800
Market Cap $20.8M
Description
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...

Get notified when there are updates to the investment portfolio of Liberty Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Liberty Wealth Management LLC with notifications on news.